VITAL: Paricalcitol reduced renal, CV risks in patients with diabetic nephropathy - Endocrine Today PDF Print
Endocrine TodayAdding 2 mcg per day of paricalcitol to renin-angiotension-aldosterone system inhibition appears to be a novel approach to lower residual renal risk for

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.